Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-1995 | 04-1994 | 04-1993 | 04-1992 | 04-1991 | |
| Sales | 2,160 | 2,910 | 3,130 | 2,772 | 4,548 |
| Cost of Goods | N/A | N/A | N/A | 1,405 | 2,476 |
| Gross Profit | 2,160 | 2,910 | 3,130 | 1,367 | 2,414 |
| Operating Expenses | 90 | 130 | 140 | 2,326 | 2,065 |
| Operating Income | 2,070 | 2,780 | 2,990 | -554 | 484 |
| Interest Expense | 2 | 3 | 80 | 74 | 81 |
| Other Income | -2,069 | -4,457 | 0 | 112 | 162 |
| Pre-tax Income | 0 | -1,680 | 2,910 | -517 | 565 |
| Net Income Continuous | 161 | -1,684 | -1,132 | -516 | 632 |
| Net Income Discontinuous | 161 | 0 | 0 | 44 | -87 |
| Net Income | $320 | $-1,680 | $-1,130 | $-472 | $478 |
| EPS Basic Total Ops | 0.48 | -2.76 | -2.64 | -1.20 | 1.24 |
| EPS Basic Continuous Ops | 0.24 | -2.76 | -2.64 | -1.31 | 1.63 |
| EPS Basic Discontinuous Ops | 0.24 | N/A | N/A | 0.11 | -0.22 |
| EPS Diluted Total Ops | 0.48 | -2.76 | -2.64 | -1.18 | 122.56 |
| EPS Diluted Continuous Ops | 0.24 | -2.76 | -2.64 | -1.30 | 162.05 |
| EPS Diluted Discontinuous Ops | 0.24 | N/A | N/A | 0.11 | -22.31 |
| EBITDA(a) | $2,070 | $2,780 | $2,990 | $-554 | $783 |